• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Comprehensive Overview of (2-cyclopentyl-2-phenylethyl)amine hydrobromide (CAS No. 175343-28-9)

(2-cyclopentyl-2-phenylethyl)amine hydrobromide (CAS No. 175343-28-9) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This compound, characterized by its unique cyclopentyl and phenylethyl structural motifs, is often explored for its potential applications in medicinal chemistry. The presence of the hydrobromide salt form enhances its solubility and stability, making it a valuable candidate for further study. Researchers are particularly interested in its role as a building block for more complex molecules, especially in the development of novel therapeutic agents.

In recent years, the demand for amine-based compounds like (2-cyclopentyl-2-phenylethyl)amine hydrobromide has surged due to their versatility in drug discovery. The compound's molecular structure allows for diverse modifications, enabling scientists to tailor its properties for specific applications. For instance, its phenylethylamine backbone is reminiscent of several bioactive molecules, which has led to investigations into its potential effects on neurological pathways. This aligns with current trends in neuroscience research, where compounds with similar frameworks are being studied for their impact on cognitive health and mood regulation.

The synthesis of (2-cyclopentyl-2-phenylethyl)amine hydrobromide involves sophisticated organic chemistry techniques, including reductive amination and salt formation. These methods ensure high purity and yield, which are critical for its use in precision medicine. The compound's CAS No. 175343-28-9 serves as a unique identifier in global chemical databases, facilitating its traceability and regulatory compliance. As the pharmaceutical industry continues to prioritize small-molecule therapeutics, compounds like this are increasingly relevant for their potential to address unmet medical needs.

One of the most frequently asked questions about (2-cyclopentyl-2-phenylethyl)amine hydrobromide revolves around its mechanism of action. While detailed pharmacological studies are still underway, preliminary data suggest that its amine group may interact with specific receptors, influencing cellular signaling pathways. This has sparked interest in its potential applications for conditions related to neurotransmitter imbalances. Additionally, its hydrobromide form is often highlighted for its improved bioavailability compared to freebase analogs, a feature that is highly sought after in drug formulation.

From an industrial perspective, (2-cyclopentyl-2-phenylethyl)amine hydrobromide is valued for its scalability and compatibility with standard manufacturing processes. Its stability under various storage conditions makes it a practical choice for large-scale production. Furthermore, the compound's structural analogs are frequently discussed in academic literature, with researchers exploring their potential in areas such as pain management and neuroprotection. These topics are particularly relevant given the growing public interest in non-opioid analgesics and neurodegenerative disease treatments.

In conclusion, (2-cyclopentyl-2-phenylethyl)amine hydrobromide (CAS No. 175343-28-9) represents a promising area of research in modern chemistry and pharmacology. Its unique chemical properties and potential therapeutic applications make it a compound of significant interest. As scientific understanding of its biological activity deepens, it is likely to play an increasingly important role in the development of next-generation pharmaceuticals. For researchers and industry professionals, staying informed about the latest advancements related to this compound is essential for leveraging its full potential.

• 40264-04-8((1S,2S)-2-phenylcyclopentan-1-amine)
• 17511-89-6((1-Phenylcyclopentyl)methanamine)
• 4442-89-1(2-cyclohexyl-2-phenylethanamine)
• 33603-06-4((S)-2-Phenylbutan-1-amine)
• 17380-54-0(1-(1-Phenylcyclohexyl)methanamine)
• 39550-30-6(3-phenylbicyclo2.2.1heptan-2-amine)
• 15301-54-9(2-phenylcyclopentanamine)
• 106498-32-2((S)-b-Isopropylphenethylamine)
• 6604-06-4(Cypenamine)
• 91245-59-9((1-phenylcyclobutyl)methanamine)